Cargando…

Benefits of Home-Based Solutions for Diagnosis and Treatment of Acute Coronary Syndromes on Health Care Costs: A Systematic Review

Diagnosing and treating acute coronary syndromes consumes a significant fraction of the healthcare budget worldwide. The pressure on resources is expected to increase with the continuing rise of cardiovascular disease, other chronic diseases and extended life expectancy, while expenditure is constra...

Descripción completa

Detalles Bibliográficos
Autores principales: Redón, Pau, Shahzad, Atif, Iqbal, Talha, Wijns, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506920/
https://www.ncbi.nlm.nih.gov/pubmed/32899338
http://dx.doi.org/10.3390/s20175006
_version_ 1783585123445243904
author Redón, Pau
Shahzad, Atif
Iqbal, Talha
Wijns, William
author_facet Redón, Pau
Shahzad, Atif
Iqbal, Talha
Wijns, William
author_sort Redón, Pau
collection PubMed
description Diagnosing and treating acute coronary syndromes consumes a significant fraction of the healthcare budget worldwide. The pressure on resources is expected to increase with the continuing rise of cardiovascular disease, other chronic diseases and extended life expectancy, while expenditure is constrained. The objective of this review is to assess if home-based solutions for measuring chemical cardiac biomarkers can mitigate or reduce the continued rise in the costs of ACS treatment. A systematic review was performed considering published literature in several relevant public databases (i.e., PUBMED, Cochrane, Embase and Scopus) focusing on current biomarker practices in high-risk patients, their cost-effectiveness and the clinical evidence and feasibility of implementation. Out of 26,000 references screened, 86 met the inclusion criteria after independent full-text review. Current clinical evidence highlights that home-based solutions implemented in primary and secondary prevention reduce health care costs by earlier diagnosis, improved patient outcomes and quality of life, as well as by avoidance of unnecessary use of resources. Economical evidence suggests their potential to reduce health care costs if the incremental cost-effectiveness ratio or the willingness-to-pay does not surpass £20,000/QALY or €50,000 limit per 20,000 patients, respectively. The cost-effectiveness of these solutions increases when applied to high-risk patients.
format Online
Article
Text
id pubmed-7506920
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75069202020-09-30 Benefits of Home-Based Solutions for Diagnosis and Treatment of Acute Coronary Syndromes on Health Care Costs: A Systematic Review Redón, Pau Shahzad, Atif Iqbal, Talha Wijns, William Sensors (Basel) Review Diagnosing and treating acute coronary syndromes consumes a significant fraction of the healthcare budget worldwide. The pressure on resources is expected to increase with the continuing rise of cardiovascular disease, other chronic diseases and extended life expectancy, while expenditure is constrained. The objective of this review is to assess if home-based solutions for measuring chemical cardiac biomarkers can mitigate or reduce the continued rise in the costs of ACS treatment. A systematic review was performed considering published literature in several relevant public databases (i.e., PUBMED, Cochrane, Embase and Scopus) focusing on current biomarker practices in high-risk patients, their cost-effectiveness and the clinical evidence and feasibility of implementation. Out of 26,000 references screened, 86 met the inclusion criteria after independent full-text review. Current clinical evidence highlights that home-based solutions implemented in primary and secondary prevention reduce health care costs by earlier diagnosis, improved patient outcomes and quality of life, as well as by avoidance of unnecessary use of resources. Economical evidence suggests their potential to reduce health care costs if the incremental cost-effectiveness ratio or the willingness-to-pay does not surpass £20,000/QALY or €50,000 limit per 20,000 patients, respectively. The cost-effectiveness of these solutions increases when applied to high-risk patients. MDPI 2020-09-03 /pmc/articles/PMC7506920/ /pubmed/32899338 http://dx.doi.org/10.3390/s20175006 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Redón, Pau
Shahzad, Atif
Iqbal, Talha
Wijns, William
Benefits of Home-Based Solutions for Diagnosis and Treatment of Acute Coronary Syndromes on Health Care Costs: A Systematic Review
title Benefits of Home-Based Solutions for Diagnosis and Treatment of Acute Coronary Syndromes on Health Care Costs: A Systematic Review
title_full Benefits of Home-Based Solutions for Diagnosis and Treatment of Acute Coronary Syndromes on Health Care Costs: A Systematic Review
title_fullStr Benefits of Home-Based Solutions for Diagnosis and Treatment of Acute Coronary Syndromes on Health Care Costs: A Systematic Review
title_full_unstemmed Benefits of Home-Based Solutions for Diagnosis and Treatment of Acute Coronary Syndromes on Health Care Costs: A Systematic Review
title_short Benefits of Home-Based Solutions for Diagnosis and Treatment of Acute Coronary Syndromes on Health Care Costs: A Systematic Review
title_sort benefits of home-based solutions for diagnosis and treatment of acute coronary syndromes on health care costs: a systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506920/
https://www.ncbi.nlm.nih.gov/pubmed/32899338
http://dx.doi.org/10.3390/s20175006
work_keys_str_mv AT redonpau benefitsofhomebasedsolutionsfordiagnosisandtreatmentofacutecoronarysyndromesonhealthcarecostsasystematicreview
AT shahzadatif benefitsofhomebasedsolutionsfordiagnosisandtreatmentofacutecoronarysyndromesonhealthcarecostsasystematicreview
AT iqbaltalha benefitsofhomebasedsolutionsfordiagnosisandtreatmentofacutecoronarysyndromesonhealthcarecostsasystematicreview
AT wijnswilliam benefitsofhomebasedsolutionsfordiagnosisandtreatmentofacutecoronarysyndromesonhealthcarecostsasystematicreview